More Exclusive Features

Academia joins CBD research boom, offering new market opportunities

Lack of significant research on the effect of cannabinoids has long been a bane to the CBD and hemp industries. But in the wake of the U.S. Drug Enforcement Administration’s decision to reschedule some cannabis-derived products, researchers are looking for ways to open and capitalize on new markets and uses. Two Stanford University researchers, Jonathan […]

Read More

Chart: Opportunity in CBD-only stores limited, but strong growth expected for other channels

As state laws around cannabidiol continue to change, stand-alone CBD stores may become a relic. According to estimates from Hemp Industry Daily in the 2018 Hemp & CBD Industry Factbook, CBD sales in the U.S. are expected to exceed $1 billion by 2020. More than half (55%) of retail respondents to a survey for the Factbook described their stores are […]

Read More

Walmart Canada ‘fact-finding’ on potential for CBD product sales

The world’s largest retailer, Walmart, is considering selling CBD products in Canada, a development that comes just days before recreational marijuana markets open in the country. But Walmart says it isn’t ready to start selling cannabidiol just yet. “As we would for any new industry, Walmart Canada has done some preliminary fact-finding on this issue,” […]

Read More

3 business takeaways from the Heineken hemp trademark case

Hemp is a booming new industry, but some of the obstacles facing entrepreneurs are decidedly old. That’s the case for a startup hemp beer seeking trademark protection for its new brand, which is running headfirst into a global alcohol giant: Heineken. The dispute centers on a Pennsylvania company’s plans to release a hemp-infused beer, Tiger […]

Read More

What Farm Bill? Hemp industry shrugs off law’s expiration

The law that ushered in the modern hemp industry in the United States has expired, but hemp growers, processors and retailers are counting on legal assurances that the nation’s experiment in allowing limited hemp production won’t immediately end.

The 2014 Farm Bill, which authorized hemp production under state research programs, expired Sunday – the last day of the federal fiscal year.

Read More

DEA takes some CBD off Schedule 1 – with FDA approval

The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.

The agency announced Thursday that drugs including “finished dosage formulations” of CBD with THC below 0.1% will be considered Schedule 5 drugs, as long as the medications have been approved by the U.S. Food and Drug Administration.

Read More